The Omega-3 Index test is an important biomarker for heart health.
The market for heart health supplements is thriving. According to
Nutrition Business Journal (
NBJ)
data, the market for heart health ingredients has the potential to
reach more than US$3 billion by 2020. With that in mind, there are many
options for consumers seeking out heart health products.
Omega-3s are considered a strong contender in this market. In fact,
research has shown long-chain omega-3s support healthy blood pressure
and cholesterol levels, normal blood clotting processes, as well as a
regular heartbeat, all of which contribute to keeping both the heart and
its arteries healthy.1,2 The anti-inflammatory nutrients found in
omega-3s can help balance the body’s level of inflammation, promoting
overall health and wellness.
Every person’s omega-3 needs are different
and the amount of EPA and DHA one would need to take to raise their
Omega-3 Index into the target range will vary. Not all omega-3s are
created equal. They vary in structure and function, and only
marine-based omega-3s (or long-chain omega-3s) contain EPA and DHA.
Krill oil provides EPA and DHA mainly in the form of phospholipids.
The body immediately recognizes phospholipid omega-3s and incorporates
them into the cells before carrying them to the tissues and organs that
need them the most, such as the heart. On the contrary, other sources of
omega-3s are delivered as triglycerides and must be processed in the
liver before they can be taken up by the cells and used by the body.
Therefore phospholipid-bound omega-3s, like krill oil, raise one’s
omega-3 index more efficiently as compared to other omega-3 oils.
In addition to omega-3 fatty acids EPA and DHA, krill contains the
essential nutrient choline, which is crucial for cell structure,
function, and signalling.
Choline is found to positively contribute to
cardiovascular, liver and cognitive health. Furthermore, the astaxanthin
found in krill oil helps keep its omega-3s naturally fresh and stable.
This is an excerpt from the article, “Raising Omega-3 Levels for Heart Health.” To continue reading, download INSIDER’s Heart Health Digital Magazine.
Andreas Berg Storsve, Ph.D., is the director of R&D at Aker BioMarine.
Storsve received his doctorate from the University of Oslo, and is a
former Fulbright Scholar at the Athinoula A. Martinos Centre for
Biomedical Imageing, Massachusetts General Hospital/Harvard Medical
School.
References
1. Chowdhury R et al. “Association of dietary, circulating, and
supplement fatty acids with coronary risk: A systematic review and
meta-analysis.”
Ann Intern Med. 2014;160:398-406.
2. Miller PE, Van Elswyk M, Alexander DD. “Long-chain omega-3 fatty
acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure:
A meta-analysis of randomized controlled trials.”
Am J Hypertens. 2014. DOI: 10.1093/ajh/hpu024.
3. Calder PC. “Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance.”
Biochim Biophys Acta. 2015;1851:469-484.
4. Ramprasath VR et al. “Enhanced increase of omega-3 index in
healthy individuals with response to 4-week n-3 fatty acid
supplementation from krill oil versus fish oil.”
Lipids Health Dis. 2013;12:178.
